Literature DB >> 30232219

CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets.

Ana M Aransay1,2, Arkaitz Carracedo3,4,5,6, Ana R Cortazar1,4, Veronica Torrano1,4, Natalia Martín-Martín1,4, Alfredo Caro-Maldonado1, Laura Camacho1,5, Ivana Hermanova1, Elizabeth Guruceaga4,7, Luis F Lorenzo-Martín4,8,9, Ruben Caloto4,8,9, Roger R Gomis4,10,11, Iñigo Apaolaza12, Victor Quesada4,13, Jan Trka14,15, Antonio Gomez-Muñoz5, Silvestre Vincent4,16,17,18, Xose R Bustelo4,8,9, Francisco J Planes12.   

Abstract

With the advent of OMICs technologies, both individual research groups and consortia have spear-headed the characterization of human samples of multiple pathophysiologic origins, resulting in thousands of archived genomes and transcriptomes. Although a variety of web tools are now available to extract information from OMICs data, their utility has been limited by the capacity of nonbioinformatician researchers to exploit the information. To address this problem, we have developed CANCERTOOL, a web-based interface that aims to overcome the major limitations of public transcriptomics dataset analysis for highly prevalent types of cancer (breast, prostate, lung, and colorectal). CANCERTOOL provides rapid and comprehensive visualization of gene expression data for the gene(s) of interest in well-annotated cancer datasets. This visualization is accompanied by generation of reports customized to the interest of the researcher (e.g., editable figures, detailed statistical analyses, and access to raw data for reanalysis). It also carries out gene-to-gene correlations in multiple datasets at the same time or using preset patient groups. Finally, this new tool solves the time-consuming task of performing functional enrichment analysis with gene sets of interest using up to 11 different databases at the same time. Collectively, CANCERTOOL represents a simple and freely accessible interface to interrogate well-annotated datasets and obtain publishable representations that can contribute to refinement and guidance of cancer-related investigations at all levels of hypotheses and design.Significance: In order to facilitate access of research groups without bioinformatics support to public transcriptomics data, we have developed a free online tool with an easy-to-use interface that allows researchers to obtain quality information in a readily publishable format. Cancer Res; 78(21); 6320-8. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 30232219     DOI: 10.1158/0008-5472.CAN-18-1669

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer.

Authors:  Goutam Chakraborty; Subhiksha Nandakumar; Rahim Hirani; Bastien Nguyen; Konrad H Stopsack; Christoph Kreitzer; Sai Harisha Rajanala; Romina Ghale; Ying Z Mazzu; Naga Vara Kishore Pillarsetty; Gwo-Shu Mary Lee; Howard I Scher; Michael J Morris; Tiffany Traina; Pedram Razavi; Wassim Abida; Jeremy C Durack; Stephen B Solomon; Matthew G Vander Heiden; Lorelei A Mucci; Andreas G Wibmer; Nikolaus Schultz; Philip W Kantoff
Journal:  Clin Cancer Res       Date:  2022-08-15       Impact factor: 13.801

2.  [Expression of superoxide dismutase 2 in breast cancer and its clinical significance].

Authors:  Jinping Li; Yaobang Liu; Qilun Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-08-30

3.  Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate Cancer.

Authors:  Luigi Ippolito; Giuseppina Comito; Elisa Giannoni; Paola Chiarugi; Matteo Parri; Marta Iozzo; Assia Duatti; Francesca Virgilio; Nicla Lorito; Marina Bacci; Elisa Pardella; Giada Sandrini; Francesca Bianchini; Roberta Damiano; Lavinia Ferrone; Giancarlo la Marca; Sergio Serni; Pietro Spatafora; Carlo V Catapano; Andrea Morandi
Journal:  Cancer Res       Date:  2022-04-01       Impact factor: 13.312

4.  Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas.

Authors:  Kati Turkowski; Frederik Herzberg; Stefan Günther; David Brunn; Andreas Weigert; Michael Meister; Thomas Muley; Mark Kriegsmann; Marc A Schneider; Hauke Winter; Michael Thomas; Friedrich Grimminger; Werner Seeger; Soni Savai Pullamsetti; Rajkumar Savai
Journal:  Cells       Date:  2020-07-22       Impact factor: 6.600

5.  Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer.

Authors:  Lorea Valcarcel-Jimenez; Alice Macchia; Natalia Martín-Martín; Ana Rosa Cortazar; Ariane Schaub-Clerigué; Mikel Pujana-Vaquerizo; Sonia Fernández-Ruiz; Isabel Lacasa-Viscasillas; Aida Santos-Martin; Ana Loizaga-Iriarte; Miguel Unda-Urzaiz; Ivana Hermanova; Ianire Astobiza; Mariona Graupera; Julia Starkova; James Sutherland; Rosa Barrio; Ana M Aransay; Arkaitz Carracedo; Verónica Torrano
Journal:  Cell Death Dis       Date:  2018-10-11       Impact factor: 8.469

6.  Up-regulation of SPC25 promotes breast cancer.

Authors:  Qian Wang; Yanhui Zhu; Zhouxiao Li; Qian Bu; Tong Sun; Hanjin Wang; Handong Sun; Xiufeng Cao
Journal:  Aging (Albany NY)       Date:  2019-08-10       Impact factor: 5.682

7.  The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non-small cell lung cancer.

Authors:  Laura Rodón; Robert U Svensson; Ezra Wiater; Matthew G H Chun; Wen-Wei Tsai; Lillian J Eichner; Reuben J Shaw; Marc Montminy
Journal:  Sci Adv       Date:  2019-07-24       Impact factor: 14.136

8.  KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer.

Authors:  Débora Cabot; Sònia Brun; Noelia Paco; Mireia M Ginesta; Núria Gendrau-Sanclemente; Baraa Abuasaker; Triana Ruiz-Fariña; Carles Barceló; Miriam Cuatrecasas; Marta Bosch; Carles Rentero; Gabriel Pons; Josep M Estanyol; Gabriel Capellà; Montserrat Jaumot; Neus Agell
Journal:  Oncogene       Date:  2021-07-31       Impact factor: 9.867

9.  Epithelial-Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma.

Authors:  Constantin Busuioc; Cristina Alexandra Ciocan-Cartita; Cornelia Braicu; Oana Zanoaga; Lajos Raduly; Monica Trif; Mihai-Stefan Muresan; Calin Ionescu; Cristina Stefan; Carmen Crivii; Nadim Al Hajjar; Simona Mǎrgǎrit; Ioana Berindan-Neagoe
Journal:  J Pers Med       Date:  2021-05-26

10.  P-REX1-Independent, Calcium-Dependent RAC1 Hyperactivation in Prostate Cancer.

Authors:  Martin J Baker; Martín C Abba; Rafael Garcia-Mata; Marcelo G Kazanietz
Journal:  Cancers (Basel)       Date:  2020-02-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.